Comment Period Extended to 3/23/2015 for Notice of Proposed Rulemaking (NPRM) for FDAAA 801 and NIH Draft Reporting Policy for NIH-Funded Trials
1 study found for:    NCT00938860
Show Display Options
Rank Status Study
1 Completed
Has Results
Sustained Virological Response (SVR) to Antiviral Treatment of Liver Transplant Recipients With Recurrent Hepatitis C
Conditions: Hepatitis C;   Liver Transplantation
Interventions: Drug: cyclosporin (Neoral);   Drug: tacrolimus (Prograf)

Indicates status has not been verified in more than two years